Natixis Advisors, L.P. Globus Medical Inc Transaction History
Natixis Advisors, L.P.
- $46 Billion
- Q2 2024
A detailed history of Natixis Advisors, L.P. transactions in Globus Medical Inc stock. As of the latest transaction made, Natixis Advisors, L.P. holds 259,512 shares of GMED stock, worth $18.3 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
259,512
Previous 230,874
12.4%
Holding current value
$18.3 Million
Previous $12.4 Million
43.52%
% of portfolio
0.04%
Previous 0.03%
Shares
22 transactions
Others Institutions Holding GMED
# of Institutions
473Shares Held
111MCall Options Held
190KPut Options Held
50.5K-
Vanguard Group Inc Valley Forge, PA10.7MShares$754 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$730 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$522 Million0.28% of portfolio
-
State Street Corp Boston, MA3.49MShares$246 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.21MShares$227 Million0.04% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $5.44B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...